相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evaluating posaconazole, its pharmacology, efficacy and safety for the prophylaxis and treatment of fungal infections
Paraskevi Panagopoulou et al.
EXPERT OPINION ON PHARMACOTHERAPY (2022)
The Role of New Posaconazole Formulations in the Treatment of Candida albicans Infections: Data from an In Vitro Pharmacokinetic-Pharmacodynamic Model
Maria-Ioanna Beredaki et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Central role of metabolism in Trypanosoma cruzi tropism and Chagas disease pathogenesis
Zongyuan Liu et al.
CURRENT OPINION IN MICROBIOLOGY (2021)
In vitro activity of posaconazole and comparators versus opportunistic filamentous fungal pathogens globally collected during 8 years
Michael A. Pfaller et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2021)
Diagnosis and identification of Leishmania species in patients with cutaneous leishmaniasis in the state of Roraima, Brazil's Amazon Region
Joseneide Viana de Almeida et al.
PARASITES & VECTORS (2021)
In Leishmania major, the Homolog of the Oncogene PES1 May Play a Critical Role in Parasite Infectivity
Miriam Algarabel et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Mevalonate kinase of Leishmania donovani protects parasite against oxidative stress by modulating ergosterol biosynthesis
Md Taj Shafi et al.
MICROBIOLOGICAL RESEARCH (2021)
Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial
Johan A Maertens et al.
LANCET (2021)
The Overview on the Pharmacokinetic and Pharmacodynamic Interactions of Triazoles
Andrzej Czyrski et al.
PHARMACEUTICS (2021)
Potent antifungal agents and use of nanocarriers to improve delivery to the infected site: A systematic review
Saraswathi Nagaraj et al.
JOURNAL OF BASIC MICROBIOLOGY (2021)
In vivo efficacy of meglumine antimoniate-loaded nanoparticles for cutaneous leishmaniasis: a systematic review
Meliana Borilli Pereira et al.
NANOMEDICINE (2021)
Combination therapy using nitro compounds improves the efficacy of experimental Chagas disease treatment
Ana Lia Mazzeti et al.
PARASITOLOGY (2021)
Hedgehog signaling pathway inhibitors: an updated patent review (2015-present)
Deborahi Quaglio et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2020)
Separation of twelve posaconazole related stereoisomers by multiple heart-cutting chiral-chiral two-dimensional liquid chromatography
Feng Xu et al.
JOURNAL OF CHROMATOGRAPHY A (2020)
Pharmacokinetics and Pharmacodynamics of Posaconazole
Lu Chen et al.
DRUGS (2020)
Autochthonous Chagas Disease — Missouri, 2018
George Turabelidze et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Epidemiology of Chagas disease in pregnant women and congenital transmission of Trypanosoma cruzi in the Americas: systematic review and meta-analysis
Kaio Henrique Santana et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2020)
Tolnaftate inhibits ergosterol production and impacts cell viability of Leishmania sp.
Eduardo Seiji Yamamoto et al.
BIOORGANIC CHEMISTRY (2020)
Hedgehog Signaling and Truncated GLI1 in Cancer
Daniel Doheny et al.
CELLS (2020)
History of the development of antifungal azoles: A review on structures, SAR, and mechanism of action
Mohammad Shafiei et al.
BIOORGANIC CHEMISTRY (2020)
Data on molecular docking of tautomers and enantiomers of ATTAF-1 and ATTAF-2 selectivty to the human/fungal lanosterol-14α-demethylase
Hamid Irannejad et al.
DATA IN BRIEF (2020)
Current and Future Prospects of Nitro-compounds as Drugs for Trypanosomiasis and Leishmaniasis
Stephen Patterson et al.
CURRENT MEDICINAL CHEMISTRY (2019)
Development of posaconazole-based analogues as hedgehog signaling pathway inhibitors
Kelly A. Teske et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Posaconazole oral suspension as salvage therapy for invasive fungal disease in patients with hematological diseases
Sudong Zhang et al.
FUTURE MICROBIOLOGY (2019)
Current advances of triazole alcohols derived from fluconazole: Design, in vitro and in silico studies
Saeed Emami et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Repurposing azole antifungals into antileishmanials: Novel 3-triazolylflavanones with promising in vitro antileishmanial activity against Leishmania major
Masoud Keighobadi et al.
PARASITOLOGY INTERNATIONAL (2019)
Pharmacokinetic/pharmacodynamic study of posaconazole delayed-release tablet in a patient with coexisting invasive aspergillosis and mucormycosis
Pannee Leelawattanachai et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2019)
Synthesis, Crystal Structure, Anti-Bone Cancer Activity and Molecular Docking Investigations of the Heterocyclic Compound 1-((2S,3S)-2-(Benzyloxy)Pentan-3-yl)-4-(4-(4-(4-Hydroxyphenyl)Piperazin-1-yl) Phenyl)-1H-1,2,4-Triazol-5(4H)-One
G. Lv et al.
JOURNAL OF STRUCTURAL CHEMISTRY (2019)
General [4+1] Cyclization Approach To Access 2,2-Disubstituted Tetrahydrofurans Enabled by Electrophilic Bifunctional Peroxides
Min Gao et al.
ORGANIC LETTERS (2019)
Advances in preclinical approaches to Chagas disease drug discovery
Fernando Villalta et al.
EXPERT OPINION ON DRUG DISCOVERY (2019)
Synthesis, structure-activity relationship and trypanocidal activity of pyrazole-imidazoline and new pyrazole-tetrahydropyrimidine hybrids as promising chemotherapeutic agents for Chagas disease
M. E. Monteiro et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Drug Solubilization by Mixtures of Cyclodextrins: Additive and Synergistic Effects
Christian Schonbeck et al.
MOLECULAR PHARMACEUTICS (2019)
Alginate Oligosaccharides Affect Mechanical Properties and Antifungal Activity of Alginate Buccal Films with Posaconazole
Marta Szekalska et al.
MARINE DRUGS (2019)
Pharmacokinetic of meglumine antimoniate encapsulated in phosphatidylserine-liposomes in mice model: A candidate formulation for visceral leishmaniasis
Samanta Etel Treiger Borborema et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Neuroinfections caused by fungi
Katarzyna Goralska et al.
INFECTION (2018)
Molecular Dynamics Simulations Reveal Structural Differences among Allelic Variants of Membrane-Anchored Cytochrome P450
Andre Fischer et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2018)
Exploring the parasite load and molecular diversity of Trypanosoma cruzi in patients with chronic Chagas disease from different regions of Brazil
Icaro Rodrigues-dos-Santos et al.
PLOS NEGLECTED TROPICAL DISEASES (2018)
Cost-effectiveness of posaconazole tablets versus fluconazole as prophylaxis for invasive fungal diseases in patients with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
Santiago Grau et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2018)
The role of the Hedgehog signaling pathway in cancer: A comprehensive review
Ana Marija Skoda et al.
BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES (2018)
An overview of azoles targeting sterol 14α-demethylase for antileishmanial therapy
Saeed Emami et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Structural analyses of Candida albicans sterol 14α-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis
Tatiana Y. Hargrove et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Early Therapeutic Drug Monitoring of Posaconazole Oral Suspension in Patients with Hematologic Malignancies
Hyeon Jeong Suh et al.
THERAPEUTIC DRUG MONITORING (2017)
In vitro antileishmanial activity of novel azoles (3-imidazolylflavanones) against promastigote and amastigote stages of Leishmania major
Azar Shokri et al.
ACTA TROPICA (2017)
Posaconazole/hydroxypropyl-β-cyclodextrin host-guest system: Improving dissolution while maintaining antifungal activity
Peixiao Tang et al.
CARBOHYDRATE POLYMERS (2016)
Posaconazole, a Second-Generation Triazole Antifungal Drug, Inhibits the Hedgehog Signaling Pathway and Progression of Basal Cell Carcinoma
Baozhi Chen et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Inclusion complexes of chlorzoxazone with β- and hydroxypropyl-β-cyclodextrin: Characterization, dissolution, and cytotoxicity
Peixiao Tang et al.
CARBOHYDRATE POLYMERS (2015)
VFV as a New Effective CYP51 Structure-Derived Drug Candidate for Chagas Disease and Visceral Leishmaniasis
Galina I. Lepesheva et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Posaconazole: Use in the Prophylaxis and Treatment of Fungal Infections
Nina M. Clark et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
CONCISE SYNTHESIS OF 1,3-DIACETOXY2-[2′-(2,4-DIFLUOROPHENYL)PROP-2′- EN-V-YL]PROPANE: AN INTERMEDIATE FOR POSACONAZOLE
Yunxiang Chen et al.
SYNTHETIC COMMUNICATIONS (2015)
Catalytic Asymmetric Bromoetherification and Desymmetrization of Olefinic 1,3-Diols with C2-Symmetric Sulfides
Zhihai Ke et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Targeted treatment for sonic hedgehog-dependent medulloblastoma
Mark W. Kieran
NEURO-ONCOLOGY (2014)
Hedgehog pathway inhibitors: a patent review (2009-present)
Matthew Kyle Hadden
EXPERT OPINION ON THERAPEUTIC PATENTS (2013)
VNI Cures Acute and Chronic Experimental Chagas Disease
Fernando Villalta et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Antitrypanosomal Lead Discovery: Identification of a Ligand-Efficient Inhibitor of Trypanosoma cruzi CYP51 and Parasite Growth
Grasiella Andriani et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
In Vitro Activity of the Antifungal Azoles Itraconazole and Posaconazole against Leishmania amazonensis
Sara Teixeira de Macedo-Silva et al.
PLOS ONE (2013)
Benznidazole and Posaconazole in Experimental Chagas Disease: Positive Interaction in Concomitant and Sequential Treatments
Livia de Figueiredo Diniz et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
Alpinetin/hydroxypropyl-β-cyclodextrin host-guest system: Preparation, characterization, inclusion mode, solubilization and stability
Shui-Xian Ma et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2012)
Successful Treatment of Old World Cutaneous Leishmaniasis Caused by Leishmania infantum with Posaconazole
A. E. Paniz Mondolfi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Advances in synthetic approach to and antifungal activity of triazoles
Kumari Shalini et al.
BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY (2011)
Itraconazole, a Commonly Used Antifungal that Inhibits Hedgehog Pathway Activity and Cancer Growth
James Kim et al.
CANCER CELL (2010)
Pharmacokinetic/Pharmacodynamic Profile of Posaconazole
Yanjun Li et al.
CLINICAL PHARMACOKINETICS (2010)
Mechanisms of Hedgehog pathway activation in cancer and implications for therapy
Suzie J. Scales et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Posaconazole (Noxafil, SCH 56592), a new azole antifungal drug, was a discovery based on the isolation and mass spectral characterization of a circulating metabolite of an earlier lead (SCH 51048)
Amin A. Nomeir et al.
JOURNAL OF MASS SPECTROMETRY (2008)
Posaconazole: An extended-spectrum triazok antifungal agent
Daryl S. Schiller et al.
CLINICAL THERAPEUTICS (2007)
Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: An externally controlled trial
Thomas J. Walsh et al.
CLINICAL INFECTIOUS DISEASES (2007)
In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts
F. Sabatelli et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole
G Benaim et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Hydroxylated analogues of the orally active broad spectrum antifungal, Sch 51048 (1), and the discovery of posaconazole [Sch 56592; 2 or (S,S)-5]
F Bennett et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Posaconazole: a broad-spectrum triazole antifungal
HA Torres et al.
LANCET INFECTIOUS DISEASES (2005)
In vitro activities of new and established triazoles against opportunistic filamentous and dimorphic fungi
GM González et al.
MEDICAL MYCOLOGY (2005)
Oral bioavailability of posaconazole in fasted healthy subjects - Comparison between three regimens and basis for clinical dosage recommendations
F Ezzet et al.
CLINICAL PHARMACOKINETICS (2005)
Pharmacokinetics of posaconazole coadministered with antacid in fasting or nonfasting healthy men
R Courtney et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Iron-catalyzed coupling reaction between 1,1-dichloro-1-alkenes and Grignard reagents
M Dos Santos et al.
SYNLETT (2004)
Posaconazole: a potent, extended-spectrum triazole anti-fungal for the treatment of serious fungal infections
R Herbrecht
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2004)
Posaconazole is a potent inhibitor of sterol 14α-demethylation in yeasts and molds
HK Munayyer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Pharmacokinetics, safety, and tolerability of oral posaconazole administered in single and multiple doses in healthy adults
R Courtney et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi
DJ Diekema et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Synthesis and antifungal activity of the 2,2,5-tetrahydrofuran regioisomers of SCH 51048
RG Lovey et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2002)
Mono N-arylation of piperazine(III):: metal-catalyzed N-arylation and its application to the novel preparations of the antifungal posaconazole and its advanced intermediate
M Hepperle et al.
TETRAHEDRON LETTERS (2002)
An intramolecular silyl transfer from the carboxylate to the hydroxyl group in sodium 4-hydroxybutyrate and its application to the synthesis of injectable antifungal posaconazole derivative, Sch 59884
P Renton et al.
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2002)
Simultaneous high-performance liquid chromatographic determination of SCH 59884 (phosphate ester prodrug of SCH 56592), SCH 207962 and SCH 56592 in dog plasma
H Kim et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2002)
Synthesis of injectable antifungal Sch 59884
GM Lee et al.
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2001)
SOB as an alternate to BOB: findings from the preparation of injectable antifungal Sch 59884
P Renton et al.
TETRAHEDRON LETTERS (2001)
Novel triazole antifungal agents
HL Hoffman et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2000)
分享论文
